In addition, the study suggests that high GSDME methylation in breast cancer patients is linked to lymph node metastasis, therefore, breast cancer patients with the risk of lymph node metastasis can be identified by GSDME (Kim et al., 2008b). This evidence concerns the gene GSDME and metastatic malignant neoplasm in the lymph nodes.